A Study to Assess the Effect of Oral Belumosudil on Inhibition of Various Proteins in the Fed State in Healthy Male Subjects
Clinical trial NCT05806567 · COMPLETED
Trial details
- NCT number
- NCT05806567
- Sponsor
- Kadmon, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-27
- Primary completion
- 2022-10-20
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.